🚨 Big news in ADPKD research!

Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:

🇫🇷 #DAPAPKD, PI @dguerrot & @ecorneclegall: 🎯 Total kidney volume evolution over 2y
🌍 #STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer: 🎯Chronic eGFR slope over 3y

🤝 Pooled analysis of 820 patients planned!